ArticleCancer immunology, immunotherapy : CII2023

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.

Alexander A Pieper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.